Search

Your search keyword '"Bolenz, C."' showing total 687 results

Search Constraints

Start Over You searched for: Author "Bolenz, C." Remove constraint Author: "Bolenz, C."
687 results on '"Bolenz, C."'

Search Results

6. Membranous NECTIN-4 expression in metastasis versus matched primary tumor more accurately predicts enfortumab vedotin response

24. Die intrinsischen molekularen Subtypen des Urothelkarzinoms bleiben während der Metastasierung stabil

27. Profitieren Patienten von zertifizierten Prostatakarzinomzentren? Ergebnisse der multizentrischen IMPROVE-Studie zu wichtigen Qualitätsindikatoren und patientenberichtetem Outcome in der operativen Therapie des lokal begrenzten Prostatakarzinoms

30. Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database

31. Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011

32. LBA75 RACE IT: A prospective, single arm, multicenter, phase II-trial to assess safety and efficacy of preoperative RAdiation therapy before radical CystEctomy combined with ImmunoTherapy in locally advanced urothelial carcinoma of the bladder (AB 65/18) – first results

33. Peri‐operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score‐weighted European multicentre study

35. Die frühe longitudinale CRP-Kinetik sagt das Ansprechen gegenüber Anti-PD-(L)1-Immuncheckpoint-Blockade im metastasiertem Urothelkarzinom voraus

36. Resistenzmechanismen des Urothelkarzinoms gegen Cisplatin und Gemcitabin

37. Die Expression des Enfortumab Vedotin Zielproteins Nectin-4 nimmt während der Metastasierung des Urothelkarzinoms stark ab

38. Vorhersage der Tumorpersistenz in der Re-TUR-B durch den Xpert® Bladder Cancer Monitor - Ergebnisse einer prospektiven multizentrischen Studie (MoniTURB Trial)

41. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks

42. Die frühe C-reaktive-Protein Kinetik sagt das Ansprechen gegenüber Anti-PD-(L)1-Immuncheckpoint-Blockade im metastasierten Urothelkarzinom voraus

43. Die frühe longitudinale CRP-Kinetik sagt das Ansprechen gegenüber Anti-PD-(L)1-Immuncheckpoint-Blockade im metastasiertem Urothelkarzinom voraus

45. Vorhersage der Tumorpersistenz in der Re-TUR-B durch den Xpert® Bladder Cancer Monitor - Ergebnisse einer prospektiven multizentrischen Studie (MoniTURB Trial)

46. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

48. External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder

49. RACE IT - A prospective, single arm, multicenter, phase II-trial to assess safety and efficacy of preoperative RAdiation therapy before radical CystEctomy combined with ImmunoTherapy in locally advanced urothelial carcinoma of the bladder (AB 65/18)

Catalog

Books, media, physical & digital resources